Nintedanib


( Last Updated : March 13, 2015)
Generic Name:
Nintedanib
Project Status:
Complete
Therapeutic Area:
Idiopathic pulmonary fibrosis
Manufacturer:
Boehringer Ingelheim (Canada) Ltd.
Call for patient/clinician input open:
Brand Name:
Ofev
Project Line:
Reimbursement Review
Project Number:
SR0426-000
Call for patient/clinician input closed:

Details


Submission Type:
Initial
Indications:
Idiopathic pulmonary fibrosis (IPF)
Recommendation Type:
List with clinical criteria and/or conditions
Final Recommendation: